Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 743

1.

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.

Ross AE, Hurley PJ, Tran PT, Rowe SP, Benzon B, Neal TO, Chapman C, Harb R, Milman Y, Trock BJ, Drake CG, Antonarakis ES.

Prostate Cancer Prostatic Dis. 2019 Oct 14. doi: 10.1038/s41391-019-0176-8. [Epub ahead of print]

PMID:
31611635
2.

Cinematic Rendering With Positive Oral Contrast: Virtual Fluoroscopy.

Rowe SP, Chu LC, Fishman EK.

J Comput Assist Tomogr. 2019 Sep/Oct;43(5):718-720. doi: 10.1097/RCT.0000000000000925.

PMID:
31609292
3.

Cross-sectional study of the relationship between cloth udder towel management, towel bacteria counts, and intramammary infection in late-lactation dairy cows.

Rowe SM, Godden SM, Royster E, Timmerman J, Boyle M.

J Dairy Sci. 2019 Oct 9. pii: S0022-0302(19)30901-4. doi: 10.3168/jds.2019-17075. [Epub ahead of print]

PMID:
31606221
4.

Cross-sectional study of the relationships among bedding materials, bedding bacteria counts, and intramammary infection in late-lactation dairy cows.

Rowe SM, Godden SM, Royster E, Timmerman J, Crooker BA, Boyle M.

J Dairy Sci. 2019 Oct 9. pii: S0022-0302(19)30900-2. doi: 10.3168/jds.2019-17074. [Epub ahead of print]

PMID:
31606215
5.

Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.

Harris JK, Wagner BD, Zemanick ET, Robertson CE, Stevens MJ, Heltshe SL, Rowe SM, Sagel SD; GOAL Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network.

Ann Am Thorac Soc. 2019 Oct 11. doi: 10.1513/AnnalsATS.201907-493OC. [Epub ahead of print]

PMID:
31604026
6.

Organizational strategies to reduce physician burnout and improve professional fulfillment.

Olson K, Marchalik D, Farley H, Dean SM, Lawrence EC, Hamidi MS, Rowe S, McCool JM, O'Donovan CA, Micek MA, Stewart MT.

Curr Probl Pediatr Adolesc Health Care. 2019 Oct 4:100664. doi: 10.1016/j.cppeds.2019.100664. [Epub ahead of print]

PMID:
31588019
7.

Black-blood cinematic rendering: A new method for cardiac CT intraluminal visualization.

Rowe SP, Chu LC, Recht HS, Lin CT, Fishman EK.

J Cardiovasc Comput Tomogr. 2019 Oct 1. pii: S1934-5925(19)30251-5. doi: 10.1016/j.jcct.2019.09.019. [Epub ahead of print]

PMID:
31586571
8.

The effectiveness of the quality improvement collaborative strategy in low- and middle-income countries: A systematic review and meta-analysis.

Garcia-Elorrio E, Rowe SY, Teijeiro ME, Ciapponi A, Rowe AK.

PLoS One. 2019 Oct 3;14(10):e0221919. doi: 10.1371/journal.pone.0221919. eCollection 2019.

9.

The future of cystic fibrosis care: a global perspective.

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30337-6. doi: 10.1016/S2213-2600(19)30337-6. [Epub ahead of print] Review.

PMID:
31570318
10.

Area Deprivation as a Risk Factor for Methicillin-resistant Staphylococcus aureus Infection in Pediatric Cystic Fibrosis.

Oates GR, Harris WT, Rowe SM, Solomon GM, Dey S, Zhu A, Hoover WC, Gutierrez HH.

Pediatr Infect Dis J. 2019 Sep 17. doi: 10.1097/INF.0000000000002419. [Epub ahead of print]

PMID:
31568067
11.

Self-valuation: Attending to the Most Important Instrument in the Practice of Medicine.

Trockel MT, Hamidi MS, Menon NK, Rowe SG, Dudley JC, Stewart MT, Geisler CZ, Bohman BD, Shanafelt TD.

Mayo Clin Proc. 2019 Oct;94(10):2022-2031. doi: 10.1016/j.mayocp.2019.04.040. Epub 2019 Sep 19.

PMID:
31543254
12.

Revealing the molecular signaling pathways of mucus stasis in cystic fibrosis.

Birket SE, Rowe SM.

J Clin Invest. 2019 Oct 1;129(10):4089-4090. doi: 10.1172/JCI131652.

13.

Geometry-Dependent Spectroscopic Contrast in Deep Tissues.

Ge X, Tang H, Wang X, Liu X, Chen S, Wang N, Ni G, Yu X, Chen S, Liang H, Bo E, Wang L, Braganza CS, Xu C, Rowe SM, Tearney GJ, Liu L.

iScience. 2019 Sep 27;19:965-975. doi: 10.1016/j.isci.2019.08.046. Epub 2019 Aug 29.

14.

Disrupting Alzheimer's With Technology: Using Data to Forge a Solution.

Kaplan E, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2019 Sep 6. pii: S1546-1440(19)30995-0. doi: 10.1016/j.jacr.2019.08.009. [Epub ahead of print] No abstract available.

PMID:
31499023
15.

CXCR4-Directed Imaging in Solid Tumors.

Werner RA, Kircher S, Higuchi T, Kircher M, Schirbel A, Wester HJ, Buck AK, Pomper MG, Rowe SP, Lapa C.

Front Oncol. 2019 Aug 14;9:770. doi: 10.3389/fonc.2019.00770. eCollection 2019.

16.

Prospective Comparison of PET Imaging with PSMA-targeted 18F-DCFPyL versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.

Rowe SP, Li X, Trock BJ, Werner RA, Frey SM, DiGianvittorio M, Bleiler K, Reyes DK, Abdallah R, Pienta KJ, Gorin MA, Pomper MG.

J Nucl Med. 2019 Aug 26. pii: jnumed.119.227793. doi: 10.2967/jnumed.119.227793. [Epub ahead of print]

PMID:
31451492
17.

Greater than the sum of the parts: Impact of radiographer clinical image interpretation.

Rowe S, O'Riordan P, Woznitza N.

J Med Radiat Sci. 2019 Sep;66(3):149-151. doi: 10.1002/jmrs.342. Epub 2019 Aug 26.

18.

Imaging of prostate cancer with positron emission tomography.

Zimmerman ME, Meyer AR, Rowe SP, Gorin MA.

Clin Adv Hematol Oncol. 2019 Aug;17(8):455-463.

PMID:
31449514
19.

Prevalence of chronic rhinosinusitis in bronchiectasis patients suspected of ciliary dyskinesia.

McCormick JP, Weeks CG, Rivers NJ, Owen JD, Kelly DR, Rowe SM, Solomon GM, Woodworth BA, Cho DY.

Int Forum Allergy Rhinol. 2019 Aug 20. doi: 10.1002/alr.22414. [Epub ahead of print]

PMID:
31430425
20.

High availability of the α7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: A pilot study using 18F-ASEM PET.

Coughlin JM, Rubin LH, Du Y, Rowe SP, Crawford JL, Rosenthal HB, Frey SM, Marshall ES, Shinehouse LK, Chen A, Speck CL, Wang Y, Lesniak WG, Minn I, Bakker A, Kamath V, Smith GS, Albert MS, Behnam Azad B, Dannals RF, Horti AG, Wong DF, Pomper MG.

J Nucl Med. 2019 Aug 16. pii: jnumed.119.230979. doi: 10.2967/jnumed.119.230979. [Epub ahead of print]

PMID:
31420499
21.

Chemical Induction of Aminoglycoside Uptake Overcomes Antibiotic Tolerance and Resistance in Staphylococcus aureus.

Radlinski LC, Rowe SE, Brzozowski R, Wilkinson AD, Huang R, Eswara P, Conlon BP.

Cell Chem Biol. 2019 Aug 6. pii: S2451-9456(19)30240-5. doi: 10.1016/j.chembiol.2019.07.009. [Epub ahead of print]

PMID:
31402316
22.

The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: findings from the EpAID study.

Pennington M, Ring H, Howlett J, Smith C, Redley M, Murphy C, Hook R, Platt A, Gilbert N, Jones E, Kelly J, Pullen A, Mander A, Donaldson C, Rowe S, Wason J, Irvine F.

J Intellect Disabil Res. 2019 Aug 8. doi: 10.1111/jir.12679. [Epub ahead of print]

PMID:
31397022
23.

Can the interplay between androgen signaling and PSMA expression be leveraged for theranostic applications?

Batra JS, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Transl Androl Urol. 2019 Jul;8(Suppl 3):S263-S264. doi: 10.21037/tau.2019.03.13. No abstract available.

24.

Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies.

Leung HM, Birket SE, Hyun C, Ford TN, Cui D, Solomon GM, Shei RJ, Adewale AT, Lenzie AR, Fernandez-Petty CM, Zheng H, Palermo JH, Cho DY, Woodworth BA, Yonker LM, Hurley BP, Rowe SM, Tearney GJ.

Sci Transl Med. 2019 Aug 7;11(504). pii: eaav3505. doi: 10.1126/scitranslmed.aav3505.

PMID:
31391319
25.

Imager-4D: New Software for Viewing Dynamic PET Scans and Extracting Radiomic Parameters from PET Data.

Rowe SP, Solnes LB, Yin Y, Kitchen G, Lodge MA, Karakatsanis NA, Rahmim A, Pomper MG, Leal JP.

J Digit Imaging. 2019 Aug 6. doi: 10.1007/s10278-019-00255-7. [Epub ahead of print]

PMID:
31388864
26.

Exclusion and Genomic Relatedness Methods for Assignment of Parentage Using Genotyping-by-Sequencing Data.

Dodds KG, McEwan JC, Brauning R, van Stijn TC, Rowe SJ, McEwan KM, Clarke SM.

G3 (Bethesda). 2019 Oct 7;9(10):3239-3247. doi: 10.1534/g3.119.400501.

27.

Applications of the Soil, Plant and Rumen Microbiomes in Pastoral Agriculture.

Attwood GT, Wakelin SA, Leahy SC, Rowe S, Clarke S, Chapman DF, Muirhead R, Jacobs JME.

Front Nutr. 2019 Jul 16;6:107. doi: 10.3389/fnut.2019.00107. eCollection 2019. Review.

28.

The application of cinematic rendering to CT evaluation of upper tract urothelial tumors: principles and practice.

Rowe SP, Chu LC, Meyer AR, Gorin MA, Fishman EK.

Abdom Radiol (NY). 2019 Jul 31. doi: 10.1007/s00261-019-02154-5. [Epub ahead of print] Review.

PMID:
31367896
29.

Enhancing CAR T-cell therapy through cellular imaging and radiotherapy.

Minn I, Rowe SP, Pomper MG.

Lancet Oncol. 2019 Aug;20(8):e443-e451. doi: 10.1016/S1470-2045(19)30461-9. Epub 2019 Jul 29. Review.

PMID:
31364596
30.

A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer.

Paller CJ, Piana D, Eshleman JR, Riel S, Denmeade SR, Isaacsson Velho P, Rowe SP, Pomper MG, Antonarakis ES, Luo J, Eisenberger MA.

Prostate. 2019 Oct;79(14):1597-1603. doi: 10.1002/pros.23883. Epub 2019 Jul 30.

PMID:
31361358
31.

Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.

Tulbah RI, Rowe SP, Solnes LB, Javadi MS.

Clin Nucl Med. 2019 Sep;44(9):e519-e521. doi: 10.1097/RLU.0000000000002724.

PMID:
31348077
32.

Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography.

Werner RA, Lapa C, Sheikhbahaei S, Marcus C, Solnes LB, Du Y, Leal JP, Buck AK, Higuchi T, Rowe SP, Javadi MS.

Nucl Med Commun. 2019 Oct;40(10):1001-1004. doi: 10.1097/MNM.0000000000001061.

PMID:
31343608
33.

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.

Chen X, Fritz A, Werner RA, Nose N, Yagi Y, Kimura H, Rowe SP, Koshino K, Decker M, Higuchi T.

Mol Imaging Biol. 2019 Jul 22. doi: 10.1007/s11307-019-01407-5. [Epub ahead of print]

PMID:
31332629
34.

Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT.

Werner RA, Thackeray JT, Pomper MG, Bengel FM, Gorin MA, Derlin T, Rowe SP.

J Clin Med. 2019 Jul 19;8(7). pii: E1060. doi: 10.3390/jcm8071060. Review.

35.

Macrocyclisation and functionalisation of unprotected peptides via divinyltriazine cysteine stapling.

Robertson NS, Walsh SJ, Fowler E, Yoshida M, Rowe SM, Wu Y, Sore HF, Parker JS, Spring DR.

Chem Commun (Camb). 2019 Aug 7;55(64):9499-9502. doi: 10.1039/c9cc05042f.

PMID:
31328756
36.

Stability of Distribution of F18 Flurpiridaz After Transient Coronary Occlusion in Pigs.

Werner RA, Koshino K, Arimitsu K, Lapa C, Javadi MS, Rowe SP, Nose N, Kimura H, Fukushima K, Higuchi T.

JACC Cardiovasc Imaging. 2019 Jul 11. pii: S1936-878X(19)30537-6. doi: 10.1016/j.jcmg.2019.05.018. [Epub ahead of print] No abstract available.

PMID:
31326498
37.
38.

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.

Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG.

Sci Adv. 2019 Jul 3;5(7):eaaw5096. doi: 10.1126/sciadv.aaw5096. eCollection 2019 Jul.

39.

[68Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas.

Breun M, Monoranu CM, Kessler AF, Matthies C, Löhr M, Hagemann C, Schirbel A, Rowe SP, Pomper MG, Buck AK, Wester HJ, Ernestus RI, Lapa C.

Front Oncol. 2019 Jun 12;9:503. doi: 10.3389/fonc.2019.00503. eCollection 2019.

40.

Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.

Sheikhbahaei S, Werner RA, Solnes LB, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Semin Nucl Med. 2019 Jul;49(4):255-270. doi: 10.1053/j.semnuclmed.2019.02.006. Epub 2019 Mar 4. Review.

PMID:
31227049
41.

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles.

Taylor-Cousar JL, Mall MA, Ramsey BW, McKone EF, Tullis E, Marigowda G, McKee CM, Waltz D, Moskowitz SM, Savage J, Xuan F, Rowe SM.

ERJ Open Res. 2019 Jun 17;5(2). pii: 00082-2019. doi: 10.1183/23120541.00082-2019. eCollection 2019 Apr.

42.

Genetic parameters of plasma and ruminal volatile fatty acids in sheep fed alfalfa pellets and genetic correlations with enteric methane emissions1.

Jonker A, Hickey SM, McEwan JC, Rowe SJ, Janssen PH, MacLean S, Sandoval E, Lewis S, Kjestrup H, Molano G, Agnew M, Young EA, Dodds KG, Knowler K, Pinares-Patiño CS.

J Anim Sci. 2019 Jul 2;97(7):2711-2724. doi: 10.1093/jas/skz162.

43.

Preoperative PSMA-targeted PET imaging: more than just a tool for prostate cancer staging?

Meyer AR, Rowe SP, Gorin MA.

BJU Int. 2019 Jul;124(1):2-3. doi: 10.1111/bju.14624. No abstract available.

PMID:
31207000
44.

Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure after Radical Prostatectomy for Prostate Cancer.

Rowe SP, Campbell SP, Mana-Ay M, Szabo Z, Allaf ME, Pienta KJ, Pomper MG, Ross AE, Gorin MA.

J Nucl Med. 2019 Jun 14. pii: jnumed.119.226514. doi: 10.2967/jnumed.119.226514. [Epub ahead of print]

PMID:
31201249
45.

Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T1 -Weighted signal increase in deep gray matter of children with brain tumors: A retrospective study.

Rowe SK, Rodriguez D, Cohen E, Grundy R, Morgan PS, Jaspan T, Dineen RA.

J Magn Reson Imaging. 2019 Jun 4. doi: 10.1002/jmri.26831. [Epub ahead of print]

PMID:
31165554
46.

A systematic review of the effectiveness of strategies to improve health care provider performance in low- and middle-income countries: Methods and descriptive results.

Rowe SY, Peters DH, Holloway KA, Chalker J, Ross-Degnan D, Rowe AK.

PLoS One. 2019 May 31;14(5):e0217617. doi: 10.1371/journal.pone.0217617. eCollection 2019.

47.

Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT.

Meyer AR, Carducci MA, Denmeade SR, Markowski MC, Pomper MG, Pierorazio PM, Allaf ME, Rowe SP, Gorin MA.

Ann Nucl Med. 2019 Aug;33(8):617-623. doi: 10.1007/s12149-019-01371-8. Epub 2019 May 30.

PMID:
31147927
48.

The next era of renal radionuclide imaging: novel PET radiotracers.

Werner RA, Chen X, Lapa C, Koshino K, Rowe SP, Pomper MG, Javadi MS, Higuchi T.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1773-1786. doi: 10.1007/s00259-019-04359-8. Epub 2019 May 30.

49.

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.

Werner RA, Bundschuh RA, Bundschuh L, Lapa C, Yin Y, Javadi MS, Buck AK, Higuchi T, Pienta KJ, Pomper MG, Lodge MA, Gorin MA, Rowe SP.

Mol Imaging Biol. 2019 May 28. doi: 10.1007/s11307-019-01375-w. [Epub ahead of print]

PMID:
31140110
50.

From the Reading Room to the Courtroom-The Use of Molecular Radionuclide Imaging in Criminal Trials.

Werner RA, Savoie B, Javadi MS, Pomper MG, Higuchi T, Lapa C, Rowe SP.

J Am Coll Radiol. 2019 May 24. pii: S1546-1440(19)30567-8. doi: 10.1016/j.jacr.2019.05.001. [Epub ahead of print]

PMID:
31132333

Supplemental Content

Support Center